The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALPINE IMMUNE SCIENCES INC COM 02083G100   89,316,174 2,253,183 SH   OTR 1 0 2,253,183 0
AUTOLUS THERAPEUTICS PLC SPON ADS 05280R100   8,869,221 1,390,160 SH   OTR 1 0 1,390,160 0
BIONOMICS LIMITED ADS 09063M205   838,901 814,467 SH   OTR 1 0 814,467 0
C4 THERAPEUTICS INC COM STK 12529R107   29,695,189 3,634,662 SH   OTR 1 0 3,634,662 0
CABALETTA BIO INC COM 12674W109   35,535,519 2,082,973 SH   OTR 1 0 2,082,973 0
CENTESSA PHARMACEUTICALS PLC SPONSORED ADS 152309100   196,620 17,400 SH   OTR 1 0 17,400 0
GH RESEARCH PLC ORDINARY SHARES G3855L106   35,290,602 3,310,563 SH   OTR 1 0 3,310,563 0
KINNATE BIOPHARMA INC COM 49705R105   5,269,742 1,981,106 SH   OTR 1 0 1,981,106 0
MERUS N V COM N5749R100   67,950,585 1,509,007 SH   OTR 1 0 1,509,007 0
NEKTAR THERAPEUTICS COM 640268108   1,932,712 2,068,842 SH   OTR 1 0 2,068,842 0
PASSAGE BIO INC COM 702712100   6,541,926 4,845,871 SH   OTR 1 0 4,845,871 0
PIERIS PHARMACEUTICALS INC COM 720795103   1,608,342 8,779,162 SH   OTR 1 0 8,779,162 0
SILENCE THERAPEUTICS PLC ADS 82686Q101   11,375,467 526,642 SH   OTR 1 0 526,642 0
STOKE THERAPEUTICS INC COM 86150R107   49,907,070 3,696,820 SH   OTR 1 0 3,696,820 0
TSCAN THERAPEUTICS INC COM 89854M101   41,483,324 5,224,600 SH   OTR 1 0 5,224,600 0